COVID-19 Pharmacy Practice Considerations Series - COVID-19 therapeutic management: an ongoing conversation

May 14, 2020

The educational series will provide resources and updated guidance for pharmacists and pharmacy technicians on the pharmacy practice considerations needed for the management of COVID-19 patients, including shortage mitigation, pharmacotherapy options, emergency preparedness, and medication safety.

Target Audience

Pharmacist

Pharmacy technicians

Learning Objectives

Pharmacist learning objectives
1.    Explain the pathogenesis of COVID-19 and evaluate the risk of thrombosis in patients with COVID-19
2.    Discuss promising treatment options for COVID-19
3.    Analyze the management of pain, agitation, and delirium in patients with Acute Respiratory Distress secondary to COVID-19


Pharmacy technician learning objectives
1.    Explain the pathogenesis of COVID-19 and evaluate the risk of thrombosis in patients with COVID-19
2.    Discuss promising treatment options for COVID-19
3.    Identify challenges and limitations to pandemic-driven research and discuss strategies to ensure safe use of experimental therapies
 

Additional Information

AttachmentSize
File Helpful Tips for Users23.36 KB
File Information for CE124.32 KB
PDF icon Presentation6.05 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Course opens: 
05/08/2020
Course expires: 
06/28/2020
Event starts: 
05/14/2020 - 1:00pm CDT
Event ends: 
05/14/2020 - 2:00pm CDT
Add to calendar: 
Live via webinar
United States

Relevant financial relationships: None of the planning committee or presenters have anything to disclose.  Hai Tran, PharmD, BCPS will discuss investigative use of drugs:  clazakizumab.  Rupali Jain, PharmD – will discuss off-label and investigative use of drugs:  Hydroxychloroquine, Lopinavir/ritonavir, Remdesivir, convalescent plasma.

Planning committee members
Jackie Stokes, BS
Manager, Pharmacy Program Services
Vizient

Gretchen Brummel
PharmD, BCPS
Pharmacy Executive Director
Vizient

Katrina Harper
PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director
Vizient

Course reviewer
Katrina Harper
PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director
Vizient

Presenters
Rupali Jain, PharmD
Co-director of Antimicrobial Stewardship
UW Medicine UWMC

Paul M. Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS
Clinical Pharmacy Practice Manager
Program Director
PGY2 Critical Care Pharmacy Practice Residency
Brigham and Women’s Hospital

Hai Tran, PharmD, BCPS
Associate Director, Drug Use Policy
Cedars-Sinai
 

Joint Accreditation Statement:

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statements:

PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours. 
Universal Activity Number: JA0006103-0000-20-097-L04-P
Universal Activity Number: JA0006103-0000-20-097-L04-T


CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
 

 

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Please login or register to take this course.